Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 3
1960 1
1963 1
1964 1
1965 4
1966 1
1967 1
1969 1
1971 3
1972 1
1973 1
1974 1
1976 3
1977 1
1978 1
1980 2
1981 2
1982 2
1983 3
1984 4
1986 1
1987 1
1999 1
2001 1
2002 1
2003 1
2004 1
2007 1
2009 1
2012 1
2013 1
2014 2
2015 3
2016 2
2017 4
2018 2
2020 2
2021 4
2022 2
2023 1
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Hybrid Closed-Loop Therapy in Adults with Type 1 Diabetes in England: Long-Term Outcomes from a Real-World Observational Study.
Liarakos AL, Crabtree TSJ, Griffin TP, Hussain S, Gallen G, Elliott J, Furlong N, Narendran P, Thabit H, Leelarathna L, Evans ML, Philbey C, Cranston I, Kamaruddin S, Htike ZZ, Sawyer L, Curtis L, Kirby J, Douek I, Chakera AJ, Saunders S, Bickerton A, Bawlchhim Z, Soar C, Wadham C, Williams C, Levitt M, Weston P, Kar P, Ryder REJ, Lumb A, Choudhary P, Wilmot EG. Liarakos AL, et al. Among authors: furlong n. Diabetes Technol Ther. 2025 Oct;27(10):820-830. doi: 10.1089/dia.2025.0165. Epub 2025 May 30. Diabetes Technol Ther. 2025. PMID: 40445741 Free article.
Issues in nursing.
Furlong NM. Furlong NM. Mich Nurse. 1984 Jul-Aug;57(4):1-2. Mich Nurse. 1984. PMID: 6565956 No abstract available.
Hybrid Closed-Loop Therapy in Adults With Type 1 Diabetes and Above-Target HbA1c: A Real-world Observational Study.
Crabtree TSJ, Griffin TP, Yap YW, Narendran P, Gallen G, Furlong N, Cranston I, Chakera A, Philbey C, Karamat MA, Saraf S, Kamaruddin S, Gurnell E, Chapman A, Hussain S, Elliott J, Leelarathna L, Ryder REJ, Hammond P, Lumb A, Choudhary P, Wilmot EG; ABCD Closed-Loop Audit Contributors. Crabtree TSJ, et al. Among authors: furlong n. Diabetes Care. 2023 Oct 1;46(10):1831-1838. doi: 10.2337/dc23-0635. Diabetes Care. 2023. PMID: 37566697 Free PMC article.
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes.
Gough SC, Bode B, Woo V, Rodbard HW, Linjawi S, Poulsen P, Damgaard LH, Buse JB; NN9068-3697 (DUAL-I) trial investigators. Gough SC, et al. Lancet Diabetes Endocrinol. 2014 Nov;2(11):885-93. doi: 10.1016/S2213-8587(14)70174-3. Epub 2014 Sep 1. Lancet Diabetes Endocrinol. 2014. PMID: 25190523 Clinical Trial.
65 results